跳至主要内容
临床试验/JPRN-jRCTs052210157
JPRN-jRCTs052210157招募中2 期

Pilot study of transurethral Deflux infusion therapy for male stress urinary incontinence after radical prostatectomy - ArtPro1

kimura Osamu0 个研究点目标入组 5 人开始时间: 2022年1月21日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
Male

入选标准

  • 1) Patients with persistent stress urinary incontinence for more than 1 year and 6 months at the time of consent, despite conservative treatment including drug treatment after radical prostatectomy
  • 2)Patients with urinary incontinence of 10g or more and 500 g or less in the 24-hour pad test of the pre-registration test
  • 3)Patients who can obtain written consent to participate in the study at their own will
  • 4)Patients aged 20 years or older at the time of consent acquisition

排除标准

  • 1) Patients with urinary tract infection
  • 2) Patients with a history of radiation therapy to the prostate
  • 3) Patients with residual urine >100ml
  • 4) Patients with artificial sphincter implantation
  • 5) Patients with PSA >0.2 ng/ml
  • 6) Patients contraindicated in the package insert of Deflux
  • 7) Other patients who are judged to be ineligible by the principal
  • investigator

研究者

发起方
kimura Osamu

相似试验

已完成
不适用
Effect of transurethral intraprostatic injection of botolinum toxin type A on chronic pelvic pain syndromechronic pelvic pain syndrome.Other inflammatory diseases of prostate
IRCT201208051853N8rology Research Center60
已完成
不适用
A randomised controlled trial of transurethral microwave thermotherapy (TUMT)rological and genital diseases: Benign prostatic hyperplasia (BPH)Urological and Genital DiseasesBenign prostatic hyperplasia (BPH)
ISRCTN24866285HS R&D Regional Programme Register - Department of Health (UK)120
撤回
3 期
Transurethral Ultrasound directed Injection of autologous Myoblasts, Fibroblasts and Collagen for the treatment of urinary incontinenceinvoluntary urine lossstress-incontinence1000499410038365
NL-OMON29996Innovacell Biotechnologie GmbH25
撤回
2 期
Safety of transurethral ultrasound directed injection of autologous myoblasts, fibroblasts and collagen in patients with urinary stress incontinence
NL-OMON30498Innovacell Biotechnologie GmbH25
进行中(未招募)
不适用
Transurethral ultrasound-directed injection of autologous myoblasts in combination with functional electrical stimulation in patients with intrinsic urinary sphincter deficiency.Stress urinary incontinence due to intrinsic sphincter deficiency (ISD).MedDRA version: 9.1Level: LLTClassification code 10066218Term: Stress urinary incontinenceMedDRA version: 9.1Level: PTClassification code 10066218Term: Stress urinary incontinence
EUCTR2009-012389-30-SIniversity Medical Centre Ljubljana, Department of Gynaecology